Ebola Virus Disease (EVD) is one of the most severe and deadly illnesses known to affect humans, with an average case fatality rate of ~50%. Based on latest guidance from WHO and CDC.
⚡ Quick Facts: Ebola Virus Disease
| 🦠 Disease Type | Severe viral hemorrhagic fever |
| 🌍 Geography | Primarily Central and West Africa |
| ⏳ Incubation Period | 2 to 21 days |
| ⚠️ Avg. Fatality Rate | ~50% (range: 25–90%) |
| 💉 Vaccine | Ervebo® approved for EBOV |
| 👨⚕️ Treatment | Supportive care + monoclonal antibodies |
What Is Ebola Virus Disease?
Caused by Orthoebolavirus genus viruses (Filoviridae family). Three of six species cause large outbreaks: Ebola virus (EBOV), Sudan virus (SUDV), and Bundibugyo virus (BDBV). Approved vaccines and treatments exist only for EBOV.
How Does Ebola Spread?
Fruit bats (Pteropodidae) are the suspected natural reservoir. Ebola does NOT spread through the air. Transmission routes:
- Animal-to-human: Contact with blood/organs of infected bats, chimps, gorillas.
- Human-to-human: Direct contact with blood, secretions, or body fluids of sick or deceased.
- Contaminated surfaces: Objects soiled with infected fluids.
- Unsafe burials: Physical contact with deceased during funeral ceremonies.
Symptoms of Ebola by Stage
| Stage | Timing | Key Symptoms |
|---|---|---|
| Early | Days 1–5 | Sudden fever, severe headache, muscle pain, fatigue, sore throat |
| Progressive | Days 5–10 | Vomiting, severe diarrhea, abdominal pain, skin rash, impaired kidney/liver |
| Severe | Day 10+ | Bleeding (minority), organ failure, confusion, shock |
Diagnosis
- RT-PCR: Gold standard — detects viral RNA; best for early detection.
- Antigen-capture tests: Rapid field diagnostics.
- Antibody ELISA: For later-stage and survivor testing.
- Virus isolation (BSL-4): Maximum biosafety lab confirmation.
Treatment Options
Optimized supportive care (IV rehydration, electrolytes, pain management, co-infection treatment) is the cornerstone. For EBOV, two FDA-approved monoclonal antibodies are strongly recommended by WHO:
- Ansuvimab / Ebanga™ (mAb114): Single monoclonal antibody approved by FDA.
- Inmazeb™ (REGN-EB3): Triple antibody cocktail with superior efficacy (PALM trial, 2018–2020 DRC outbreak).
Approved Vaccines
- Ervebo® (rVSV-ZEBOV — Merck): FDA-approved, ~97.5% efficacy, used in outbreak response. SAGE updated recommendations July 2024. Available via Gavi Preventive Ebola Vaccination.
- Zabdeno® + Mvabea® (Janssen): Two-dose preventive regimen for healthcare workers.
Prevention & Control
- Avoid contact with fruit bats, primates, and wildlife in endemic areas.
- Do not handle or consume raw bushmeat.
- Avoid direct contact with blood/body fluids of sick or deceased persons.
- Practice safe and dignified burials per WHO protocols.
- Healthcare workers: use PPE strictly and follow IPC protocols.
- Get vaccinated (Ervebo®) if in or traveling to outbreak zones.
Major Historical Outbreaks
- 1976: Simultaneous outbreaks in Nzara (South Sudan) and Yambuku (DRC) — first documented cases.
- 1995 — Kikwit, DRC: 254 deaths out of 315 confirmed cases (~81% case fatality rate).
- 2014–2016 — West Africa: Largest outbreak — 28,600+ cases, 11,300+ deaths across Guinea, Sierra Leone, Liberia. See WHO final reports.
- 2018–2020 — North Kivu, DRC: 3,481 cases, 2,299 deaths.
- 2022 — Uganda: Sudan virus outbreak highlighting urgent need for SVD vaccines.
Survivor Care & Long-Term Health
Survivors may experience Post-Ebola Syndrome (PES): joint/muscle pain, uveitis, hearing loss, fatigue, PTSD. The virus persists in immune-privileged sites (testes, eye, CNS). Male survivors must follow safer sex practices and monthly semen testing until two consecutive negatives. Pregnant/breastfeeding survivors need specialized follow-up.
⚠️ When to Seek Immediate Medical Care
Seek emergency care immediately if you:
- Develop sudden fever, vomiting, or severe diarrhea after traveling to an Ebola-affected area.
- Have had close contact with a confirmed/suspected Ebola patient.
- Were exposed to blood or body fluids of wild animals in an endemic region.
Isolate, call ahead, and seek care immediately — early treatment saves lives.
Frequently Asked Questions (FAQ)
Does Ebola spread through the air?
No. Ebola does not spread via airborne transmission. It requires direct contact with blood or body fluids of an infected person or contaminated surfaces.
Is there a cure for Ebola?
Two FDA-approved monoclonal antibody therapies exist for EBOV (Ansuvimab/Ebanga™ and Inmazeb™) alongside optimized supportive care. No approved treatments exist yet for Sudan or Bundibugyo viruses.
Is there a vaccine against Ebola?
Yes. Ervebo® (Merck) is FDA-approved with ~97.5% efficacy against EBOV. Zabdeno® + Mvabea® (Janssen) for preventive vaccination of healthcare workers. No approved vaccines for Sudan/Bundibugyo strains yet.
How long does the incubation period last?
The incubation period is 2 to 21 days from exposure. People cannot transmit the disease before symptoms appear.
Can Ebola survivors spread the virus?
Once blood tests negative, survivors are generally not contagious. However, the virus can persist in semen for up to 15 months — safer sex practices and monthly semen testing are strongly recommended.
Has Ebola been detected in Saudi Arabia?
No local Ebola cases have ever been reported in Saudi Arabia. The Saudi Ministry of Health and Saudi CDC (Weqaي) continuously monitor global disease surveillance.
References & Sources
- 🌐 World Health Organization (WHO) — Ebola Fact Sheet
- 🔬 CDC — Ebola Virus Disease
- 💊 FDA — Ebola Approvals
- 💉 Gavi Vaccine Alliance
- 🏛️ NIH — Ebola
- 🌍 UNICEF — Ebola Emergency Response
Disclaimer: For educational purposes only. Not medical advice. Seek immediate care if you have potential Ebola exposure.
